Piper Jaffray Upgrades Wright Medical (WMGI) to Overweight

JPMorgan Assumes Wright Medical (WMGI) at Overweight

JPMorgan assumed coverage on Wright Medical (NASDAQ: WMGI) with a Overweight rating and a price target of $26.00.

For an analyst ratings summary and ratings history on Wright Medical click here. For more ratings news on Wright Medical click here.

Shares of Wright Medical closed at $20.52 yesterday.

Leerink Partners Remains Bullish on Wright Medical Group (WMGI) Following Large Joint Business Divestiture

Leerink Partners reiterated an Outperform rating and $25.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's divestiture of TRNX's legacy large joint business. The divestiture will result in lowered revenue guidance to $668-678M vs. $705-$715 reflecting the large joint business removal. however,... More

Needham & Company Reiterates Buy on Wright Medical Group (WMGI) Following A Binding Offer For Large Joints business

Needham & Company reiterated a Buy rating and $24.00 price target on Wright Medical Group (NASDAQ: WMGI) as the company received a binding offer for its Large Joints business from Corin for $33M of cash. Management has lowered its 2016 revenue guidance to account for the deal.... More

Corin Offers to Acquire Wright Medical's (WMGI) Hip/Knee Business in $33M Deal

Wright Medical Group N.V. (Nasdaq: WMGI) announced that it has received a binding offer under which Corin Orthopaedics Holdings Limited (Corin) would acquire the large joints (hip/knee) business from Wright Medical Group N.V. Under the terms of the offer and following a consultation process with the employee works council in France, Corin would acquire all of the legacy Tornier large joints business for a purchase price of 29.7 million in cash, or approximately $33 million based on todays currency exchange rates, subject to customary closing adjustments. Net after-tax proceeds for Wright Medical, after... More